New York S 7499: Requires certain manufacturers of prescription drugs to notify the drug utilization review board of the proposed increase of the wholesale acquisition cost of such prescription drugs

Status: REFERRED TO HEALTH (as of 2022-05-24)

State: New York · Session: 2021-2022 · Bill: S 7499

Sponsors: SALAZAR, MAY

View New York S 7499 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.